| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/03/2001 | WO2000074695A3 Tanacetum parthenium extract |
| 05/03/2001 | WO2000065028A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 05/03/2001 | DE19951671A1 2-(4,6-Dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionssäure-Natriumsalz und seine Verwendung als Endothelinantagonist and its use as an endothelin antagonist |
| 05/03/2001 | DE19951360A1 Substituierte Indole Substituted indoles |
| 05/03/2001 | DE19949202A1 Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure Transdermal therapeutic system for the delivery of acetylsalicylic acid and / or salicylic acid |
| 05/03/2001 | CA2389127A1 Human sphingosine kinase gene |
| 05/03/2001 | CA2389034A1 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 05/03/2001 | CA2389012A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 05/03/2001 | CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | CA2388338A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | CA2388203A1 Microbe, microbial exopolysaccharide, and uses thereof |
| 05/03/2001 | CA2388130A1 Molecularly imprinted polymers produced by template polymerisation |
| 05/03/2001 | CA2387857A1 Tissue factor antagonists and methods of use thereof |
| 05/03/2001 | CA2387685A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 05/02/2001 | EP1095933A1 Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1095651A2 Multipor food protection |
| 05/02/2001 | EP1095274A1 Trifunctional reagent for conjugation to a biomolecule |
| 05/02/2001 | EP1095143A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 05/02/2001 | EP1095025A2 Benzimidazoles, production thereof and use thereof as medicaments |
| 05/02/2001 | EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1094712A1 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0863866B1 Butyrate prodrugs of lactic acid |
| 05/02/2001 | CN1293712A Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 05/02/2001 | CN1293679A New pentasaccharides, their methods of production and pharmaceutical compositions containing same |
| 05/02/2001 | CN1293661A Pyridazinone hydrochloride compound and method for producing the same |
| 05/02/2001 | CN1293577A Iron-dextran compound for use as component in therapeutical composition for prophylaxis or treatment of iron-deficiency, process for producing said iron-dextran compound and use of said compound for p |
| 05/02/2001 | CN1293192A New benzothiophene, benzofuran and indole compounds, preparation method therefor and medicine composition containing same |
| 05/02/2001 | CN1293056A Tea for cleaning human blood |
| 05/02/2001 | CN1065244C Tricyclic benzazepine vasopressin antagonists |
| 05/02/2001 | CN1065138C Seaweed acid calcium medicated plaster |
| 05/01/2001 | US6225501 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock |
| 05/01/2001 | US6225494 Trisubstituted phenyl derivatives having retinoid agonist or inverse agonist type biological activity |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225354 Subjecting unsaponified beeswax to liquid extraction with liquid organic extractant in which primary aliphatic alcohols are soluble; recovering alcohol mixture and isolating alcohols |
| 05/01/2001 | US6225309 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 05/01/2001 | US6225302 Amidino protease inhibitors |
| 05/01/2001 | US6225287 Crystalline forms |
| 05/01/2001 | US6224875 Tanacetum parthenium extract and method of obtaining same |
| 05/01/2001 | US6224862 Mixture of prothrombinase and protein; anticoagulant |
| 05/01/2001 | CA2150939C Stable protein: phospholipid compositions and methods |
| 05/01/2001 | CA1341223C Dna clone of human tissue factor inhibitor |
| 05/01/2001 | CA1341219C Site specific mutagenesis in alpha-1-antitrypsin |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029049A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029005A1 Bicyclic vasopressin agonists |
| 04/26/2001 | WO2001028978A1 Bicyclic amino acids as pharmaceutical agents |
| 04/26/2001 | WO2001028603A1 Formulations for delivery of osteogenic proteins |
| 04/26/2001 | WO2001028492A2 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | WO2000071153A3 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors |
| 04/26/2001 | WO2000066753A3 Modified vitamin k-dependent polypeptides |
| 04/26/2001 | WO2000061609B1 Prodrugs of thrombin inhibitors |
| 04/26/2001 | WO2000061121A3 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy |
| 04/26/2001 | WO2000059903A9 Universal die holder assembly for press brakes |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | DE19949589A1 Differentiating immature myeloid precursor cells, useful for producing active granulocytes for treatment of infections, comprises in vitro culture |
| 04/26/2001 | CA2387886A1 Bicyclic vasopressin agonists |
| 04/26/2001 | CA2387558A1 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/25/2001 | EP1094079A2 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1094078A2 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1093814A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 04/25/2001 | EP1093720A1 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093378A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1292377A Synthesis preparation method of high-effective hemostatic notoginseng extract |
| 04/25/2001 | CN1292376A Synthesis method for preparing high-effective hemostatic notogiseng extract |
| 04/25/2001 | CN1064956C Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same |
| 04/25/2001 | CN1064848C Chinese herbal medicine preparation for glaucoma |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6222018 Antibody which binds to transcription factor; for detection in samples; for screening expression libraries |
| 04/24/2001 | US6221898 Anticoagulants |
| 04/24/2001 | US6221886 Thio acid derived monocyclic N-heterocyclics as anticoagulants |
| 04/24/2001 | US6221575 Preserving blood; exposing blood trehalose and drying in presence of a carbohydrate |
| 04/24/2001 | US6221349 Adeno-associated vectors for expression of factor VIII by target cells |
| 04/24/2001 | CA1341216C Human .alpha.-1-antitrypsin derivatives, and a production process |
| 04/19/2001 | WO2001027623A2 Isoagglutinin-depleted blood compositions and methods of making same |
| 04/19/2001 | WO2001027304A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 04/19/2001 | WO2001027303A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | WO2001027147A1 A novel molecule |
| 04/19/2001 | WO2001027141A1 Inhibitors of factor xa having an arginine or arginine aldehyde mimic |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027090A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRINαvβ3 ANTAGONISM |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027086A1 Tetrahydroquinoline derivatives |
| 04/19/2001 | WO2001027082A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN αvβ3 ANTAGONISTS |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001026676A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001026637A2 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |